cetylpyridinium chloride anhydrous has been researched along with carnitine in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Kaup, FJ; Neumann, S; Thuere, S; Welling, H | 1 |
Cao, Y; Han, ZW; Li, P; Qu, HJ; Wang, CB; Wang, LX | 1 |
Adeli, K; Bevilacqua, V; Chan, MK; Chen, YK; Kyriakopoulou, L; Raizman, JE; Schulze, A; Teodoro-Morrison, T; Wan, B; Yazdanpanah, M | 1 |
1 trial(s) available for cetylpyridinium chloride anhydrous and carnitine
Article | Year |
---|---|
Single dose administration of L-carnitine improves antioxidant activities in healthy subjects.
Topics: Administration, Oral; Antioxidants; Carnitine; Catalase; Dose-Response Relationship, Drug; Glutathione Peroxidase; Health; Humans; Superoxide Dismutase; Time Factors | 2011 |
2 other study(ies) available for cetylpyridinium chloride anhydrous and carnitine
Article | Year |
---|---|
Plasma L-carnitine concentration in healthy dogs and dogs with hepatopathy.
Topics: Animals; Carnitine; Dog Diseases; Dogs; Female; Health; Liver Diseases; Male; Retrospective Studies | 2007 |
Dynamic biological changes in metabolic disease biomarkers in childhood and adolescence: A CALIPER study of healthy community children.
Topics: Adolescent; Amino Acids; Biomarkers; Carnitine; Child; Child, Preschool; Cohort Studies; Female; Health; Humans; Infant, Newborn; Male; Metabolism, Inborn Errors; Reference Values; Residence Characteristics; Young Adult | 2015 |